Ginkgo Bioworks Holdings (DNA) Equity Income (2020 - 2023)
Ginkgo Bioworks Holdings posted quarterly Equity Income of -$1.1 million for Q4 2023, down 111.19% year-on-year from $10.0 million in Q4 2022, and down 1570.15% on a QoQ basis from -$67000.0 in Q2 2023.
Ginkgo Bioworks Holdings (DNA) has 4 years of Equity Income data on file, last reported at -$1.1 million in Q4 2023.
- For the quarter ending Q4 2023, Equity Income fell 111.19% year-over-year to -$1.1 million; the trailing twelve-month figure through Sep 2024 stood at -$1.1 million (down 113.18% YoY), and the FY2023 full-year result was -$2.6 million, up 93.98% from the prior year.
- Equity Income for Q4 2023 stood at -$1.1 million, down from -$67000.0 in the prior quarter.
- Across five years, Equity Income topped out at $59.9 million in Q4 2021 and bottomed at -$39.7 million in Q3 2021.
- The 4-year median for Equity Income is -$4.3 million (2021), against an average of -$5.1 million.
- Peak annual rise in Equity Income reached 368.11% in 2021, while the deepest fall reached 16630.38% in 2021.
- A 4-year view of Equity Income shows it stood at -$22.3 million in 2020, then surged by 368.11% to $59.9 million in 2021, then tumbled by 83.31% to $10.0 million in 2022, then plunged by 111.19% to -$1.1 million in 2023.
- The last three Equity Income figures came in at -$1.1 million (Q4 2023), -$67000.0 (Q2 2023), and -$1.4 million (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 235,807.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Ginkgo Bioworks Holdings | 542.03 Mn | 542.03 Mn | 16.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -1.12 Mn |
| Jun 30, 2023 | -67,000.00 |
| Mar 31, 2023 | -1.45 Mn |
| Dec 31, 2022 | 10.00 Mn |
| Sep 30, 2022 | -22.71 Mn |
| Jun 30, 2022 | -10.17 Mn |
| Mar 31, 2022 | -20.89 Mn |
| Dec 31, 2021 | 59.92 Mn |
| Sep 30, 2021 | -39.65 Mn |
| Jun 30, 2021 | -4.35 Mn |
| Mar 31, 2021 | -12.70 Mn |
| Dec 31, 2020 | -22.35 Mn |
| Sep 30, 2020 | -237,000.00 |